Welcome Message
On behalf of the organizing committee, I would like to welcome you to the 9th edition of Antibody Therapeutic Conference (ATC) - 2022 Antibody Therapeutics Conference: Extended Application of Antibody, which will be held in the National Biotechnology Research Park (Taipei, Taiwan) on Nov 15th.
The application of antibody therapeutics remains a growing research area today, especially in the treatment for cancers, immune-mediated diseases and infectious diseases. Particularly, immunotherapies including antibody-mediated tumor regression, checkpoint blockade, antibody drug conjugates (ADC) and Chimeric antigen receptor T-cell therapy (CAR-T) are regarded as potential strategies to cure cancers.
To showcase a broad scope of remarkable achievements, this year the Antibody Therapeutics Conference (ATC) will focus on the extended application of antibody.
Taiwan Antibody Association(TAA), the ATC organizer, was establishment back in 2012 with the mission to facilitate the research and industrial development of antibody drugs and related technologies in Taiwan. By hosting international conference, we aim to provide a platform for the attendees to connect and communicate, along with opportunities for students, postdoctoral fellows and other participants in the field to learn new knowledge and join discussion.
Last but not least, we hope this conference is able to stimulate interactions between senior experts and young scientists working on antibody therapeutics. We sincerely hope this annual event will contribute to the advancement of antibody therapeutics and you will find it informative, insightful and inspiring.
Chung-Hsiun Herbert Wu, Ph.D.
Chairman of Taiwan Antibody Association;
President of Development Center for Biotechnology
Registration Is Now Open.
1、TAA個人會員 1,000
TAA Member NTD 1,000
(現在加入會員僅需1,000元)
2、非會員 1,200
General Audience NTD 1,200
3、TAA團體會員/主辦單位 員工報名
主辦單位:中研院生醫轉譯研究中心、財團法人生物技術開發中心
永久團體會員:台灣醣聯、基亞
團體會員:圓祥生命、生達化學、奇異亞洲醫療設備、中天生技、抗體王生技、全福生技、台康生技、進階生技、智合精準、免疫功坊、國光生技、永昕生技